Potential drug–drug and drug–condition interactions among fibromyalgia patients initiating pregabalin or duloxetine: prevalence and health care expenditure impact
Home → Pain → Potential drug–drug and drug–condition interactions among fibromyalgia patients initiating pregabalin or duloxetine: prevalence and health care expenditure impact
